Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB233 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	II
2	2	119THCONGRESS
3	3	1
4	4	STSESSION S. 233
5	5	To amend the Office of National Drug Control Policy Reauthorization Act
6	6	of 2006 to modify the authority of the Office of National Drug Control
7	7	Policy with respect to the World Anti-Doping Agency, and for other
8	8	purposes.
9	9	IN THE SENATE OF THE UNITED STATES
10	10	JANUARY23, 2025
11	11	Mrs. B
12	12	LACKBURN (for herself, Mr. VANHOLLEN, Mrs. CAPITO, Mr.
13	13	B
14	14	LUMENTHAL, and Mr. WICKER) introduced the following bill; which was
15	15	read twice and referred to the Committee on Commerce, Science, and
16	16	Transportation
17	17	A BILL
18	18	To amend the Office of National Drug Control Policy Reau-
19	19	thorization Act of 2006 to modify the authority of the
20	20	Office of National Drug Control Policy with respect to
21	21	the World Anti-Doping Agency, and for other purposes.
22	22	Be it enacted by the Senate and House of Representa-1
23	23	tives of the United States of America in Congress assembled, 2
24	24	SECTION 1. SHORT TITLE. 3
25	25	This Act may be cited as the ‘‘Restoring Confidence 4
26	26	in the World Anti-Doping Agency Act of 2025’’. 5
27	27	VerDate Sep 11 2014 18:01 Feb 19, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S233.IS S233
28	28	ssavage on LAPJG3WLY3PROD with BILLS 2
29	29	•S 233 IS
30	30	SEC. 2. AUTHORITY OF NATIONAL DRUG CONTROL POLICY 1
31	31	WITH RESPECT TO THE WORLD ANTI-DOPING 2
32	32	AGENCY. 3
33	33	Section 701 of the Office of National Drug Control 4
34	34	Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is 5
35	35	amended— 6
36	36	(1) in subsection (a)— 7
37	37	(A) by amending paragraph (1) to read as 8
38	38	follows: 9
39	39	‘‘(1) U
40	40	NITED STATES OLYMPIC AND 10
41	41	PARALYMPIC COMMITTEE .—The term ‘United States 11
42	42	Olympic and Paralympic Committee’ means the or-12
43	43	ganization established by chapter 2205 of title 36, 13
44	44	United States Code.’’; 14
45	45	(B) in paragraph (3), by striking ‘‘(36 15
46	46	U.S.C. 22501(b)(1))’’ and inserting ‘‘(36 16
47	47	U.S.C. 220501(b)(1))’’; 17
48	48	(C) by redesignating paragraphs (1) and 18
49	49	(3) as paragraphs (4) and (1), respectively, and 19
50	50	moving the paragraphs so as to appear in nu-20
51	51	meric order; and 21
52	52	(D) by inserting after paragraph (2) the 22
53	53	following: 23
54	54	‘‘(3) I
55	55	NDEPENDENT ATHLETE .—The term 24
56	56	‘independent athlete’ means an Olympic or 25
57	57	VerDate Sep 11 2014 18:01 Feb 19, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S233.IS S233
58	58	ssavage on LAPJG3WLY3PROD with BILLS 3
59	59	•S 233 IS
60	60	Paralympic athlete who does not serve, in any capac-1
61	61	ity— 2
62	62	‘‘(A) on the International Olympic Com-3
63	63	mittee; 4
64	64	‘‘(B) on the International Paralympic 5
65	65	Committee; 6
66	66	‘‘(C) at an international sports federation 7
67	67	recognized by the International Olympic Com-8
68	68	mittee or the International Paralympic Com-9
69	69	mittee; 10
70	70	‘‘(D) on the United States Olympic and 11
71	71	Paralympic Committee; or 12
72	72	‘‘(E) at the World Anti-Doping Agency.’’; 13
73	73	(2) in subsection (b)— 14
74	74	(A) by striking ‘‘United States Olympic 15
75	75	Committee’’ each place it appears and inserting 16
76	76	‘‘United States Olympic and Paralympic Com-17
77	77	mittee’’; 18
78	78	(B) in paragraph (5), by striking the pe-19
79	79	riod at the end and inserting ‘‘; and’’; and 20
80	80	(C) by adding at the end the following: 21
81	81	‘‘(6) carry out responsibilities with respect to 22
82	82	the World Anti-Doping Agency, as described in sub-23
83	83	section (d).’’; and 24
84	84	(3) by adding at the end the following: 25
85	85	VerDate Sep 11 2014 18:01 Feb 19, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\S233.IS S233
86	86	ssavage on LAPJG3WLY3PROD with BILLS 4
87	87	•S 233 IS
88	88	‘‘(d) AUTHORITYWITHRESPECT TO THE WORLD 1
89	89	A
90	90	NTI-DOPINGAGENCY.— 2
91	91	‘‘(1) I
92	92	N GENERAL.—The Office of National 3
93	93	Drug Control Policy, in consultation with the United 4
94	94	States Anti-Doping Agency, the United States Olym-5
95	95	pic and Paralympic Committee, and the Team USA 6
96	96	Athletes’ Commission, shall— 7
97	97	‘‘(A) use all available tools to ensure 8
98	98	that— 9
99	99	‘‘(i) the World Anti-Doping Agency 10
100	100	has a credible and independent governance 11
101	101	model that provides for fair representation 12
102	102	of the United States; 13
103	103	‘‘(ii) the World Anti-Doping Agency 14
104	104	fully implements all governance reforms, 15
105	105	including a proper conflict-of-interest pol-16
106	106	icy for all members of the Executive Com-17
107	107	mittee, the Foundation Board, and all rel-18
108	108	evant expert advisory groups, standing 19
109	109	committees, permanent special committees, 20
110	110	and working groups of the World Anti- 21
111	111	Doping Agency; and 22
112	112	‘‘(iii) independent athletes from the 23
113	113	United States and other democratic coun-24
114	114	tries, or representatives of such athletes, 25
115	115	VerDate Sep 11 2014 18:01 Feb 19, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\S233.IS S233
116	116	ssavage on LAPJG3WLY3PROD with BILLS 5
117	117	•S 233 IS
118	118	have decision-making roles on the Execu-1
119	119	tive Committee and the Foundation Board, 2
120	120	and in all relevant expert advisory groups, 3
121	121	standing committees, permanent special 4
122	122	committees, and working groups, of the 5
123	123	World Anti-Doping Agency; 6
124	124	‘‘(B) demonstrate leadership within the 7
125	125	global community; 8
126	126	‘‘(C) have strict standards that work to-9
127	127	ward countering doping in every form, including 10
128	128	by countering systemic fraud through doping 11
129	129	involving— 12
130	130	‘‘(i) governmental law enforcement, 13
131	131	intelligence, or anti-doping institutions; 14
132	132	‘‘(ii) sporting organizations; or 15
133	133	‘‘(iii) athlete support personnel; and 16
134	134	‘‘(D) work collaboratively with democratic 17
135	135	countries. 18
136	136	‘‘(2) D
137	137	ETERMINATION.— 19
138	138	‘‘(A) I
139	139	N GENERAL.—Not later than 90 20
140	140	days after the date of the enactment of this 21
141	141	subsection, the Office of National Drug Control 22
142	142	Policy, in consultation with the United States 23
143	143	Anti-Doping Agency, the United States Olympic 24
144	144	and Paralympic Committee, and the Team USA 25
145	145	VerDate Sep 11 2014 18:01 Feb 19, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\S233.IS S233
146	146	ssavage on LAPJG3WLY3PROD with BILLS 6
147	147	•S 233 IS
148	148	Athletes’ Commission, shall make a determina-1
149	149	tion as to whether the World Anti-Doping 2
150	150	Agency— 3
151	151	‘‘(i) has a credible and independent 4
152	152	governance model that provides for fair 5
153	153	representation of the United States; 6
154	154	‘‘(ii) fully implements all governance 7
155	155	reforms, including a proper conflict-of-in-8
156	156	terest policy described in paragraph 9
157	157	(1)(A)(ii); and 10
158	158	‘‘(iii) allows independent athletes from 11
159	159	the United States and other democratic 12
160	160	countries, or representatives of such ath-13
161	161	letes, to have decision-making roles on the 14
162	162	Executive Committee and the Foundation 15
163	163	Board, and in all relevant expert advisory 16
164	164	groups, standing committees, permanent 17
165	165	special committees, and working groups, of 18
166	166	the World Anti-Doping Agency. 19
167	167	‘‘(B) A
168	168	CCOUNTABILITY.—In the case of a 20
169	169	determination under subparagraph (A) that the 21
170	170	World Anti-Doping Agency does not have such 22
171	171	a governance model, has not fully implemented 23
172	172	such governance reforms, or has not allowed de-24
173	173	cision-making roles described in clause (iii) of 25
174	174	VerDate Sep 11 2014 18:01 Feb 19, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\S233.IS S233
175	175	ssavage on LAPJG3WLY3PROD with BILLS 7
176	176	•S 233 IS
177	177	that subparagraph, the Office of National Drug 1
178	178	Control Policy, in consultation with the United 2
179	179	States Anti-Doping Agency, the United States 3
180	180	Olympic and Paralympic Committee, and the 4
181	181	Team USA Athletes’ Commission, shall— 5
182	182	‘‘(i) use all available tools to ensure 6
183	183	that the United States has fair representa-7
184	184	tion in the World Anti-Doping Agency, in-8
185	185	cluding— 9
186	186	‘‘(I) on the Executive Committee; 10
187	187	‘‘(II) on the Foundation Board; 11
188	188	and 12
189	189	‘‘(III) in all relevant expert advi-13
190	190	sory groups, standing committees, 14
191	191	permanent special committees, and 15
192	192	working groups of the World Anti- 16
193	193	Doping Agency; and 17
194	194	‘‘(ii) not later than 180 days after the 18
195	195	date on which the determination under 19
196	196	subparagraph (A) is made, issue a report 20
197	197	that describes the barriers to participation 21
198	198	and fair representation of the United 22
199	199	States on the Executive Committee, the 23
200	200	Foundation Board, and all relevant expert 24
201	201	advisory groups, standing committees, per-25
202	202	VerDate Sep 11 2014 18:01 Feb 19, 2025 Jkt 059200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\S233.IS S233
203	203	ssavage on LAPJG3WLY3PROD with BILLS 8
204	204	•S 233 IS
205	205	manent special committees, and working 1
206	206	groups of the World Anti-Doping Agency. 2
207	207	‘‘(3) V
208	208	OLUNTARY NONPAYMENT OF DUES .— 3
209	209	‘‘(A) I
210	210	N GENERAL.—In the case of a deter-4
211	211	mination under paragraph (2)(A) that the 5
212	212	World Anti-Doping Agency does not have a gov-6
213	213	ernance model that provides for fair representa-7
214	214	tion of the United States, has not fully imple-8
215	215	mented governance reforms, or has not allowed 9
216	216	decision-making roles described in clause (iii) of 10
217	217	that subparagraph, the Office of National Drug 11
218	218	Control Policy, in consultation with the appro-12
219	219	priate committees of Congress, may voluntarily 13
220	220	withhold up to the full amount of membership 14
221	221	dues to the World Anti-Doping Agency. 15
222	222	‘‘(B) A
223	223	PPROPRIATE COMMITTEES OF CON -16
224	224	GRESS DEFINED.—In this paragraph, the term 17
225	225	‘appropriate committees of Congress’ means— 18
226	226	‘‘(i) the Subcommittee on Consumer 19
227	227	Protection, Product Safety, and Data Se-20
228	228	curity of the Committee on Commerce, 21
229	229	Science, and Transportation of the Senate 22
230	230	(or a successor subcommittee); 23
231	231	‘‘(ii) the Subcommittee on Financial 24
232	232	Services and General Government of the 25
233	233	VerDate Sep 11 2014 18:01 Feb 19, 2025 Jkt 059200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\S233.IS S233
234	234	ssavage on LAPJG3WLY3PROD with BILLS 9
235	235	•S 233 IS
236	236	Committee on Appropriations of the Sen-1
237	237	ate (or a successor subcommittee); 2
238	238	‘‘(iii) the Subcommittee on Oversight 3
239	239	and Investigations of the Committee on 4
240	240	Energy and Commerce of the House of 5
241	241	Representatives (or a successor sub-6
242	242	committee); and 7
243	243	‘‘(iv) the Subcommittee on Financial 8
244	244	Services and General Government of the 9
245	245	Committee on Appropriations of the House 10
246	246	of Representatives (or a successor sub-11
247	247	committee). 12
248	248	‘‘(4) S
249	249	PENDING PLAN.—Not later than 30 days 13
250	250	before the Office of National Drug Control Policy 14
251	251	obligates funds to the World Anti-Doping Agency, 15
252	252	the Office of National Drug Control Policy shall sub-16
253	253	mit to the Committee on Appropriations of the Sen-17
254	254	ate and the Committee on Appropriations of the 18
255	255	House of Representatives a spending plan and expla-19
256	256	nation of proposed uses of such funds.’’. 20
257	257	Æ
258	258	VerDate Sep 11 2014 18:01 Feb 19, 2025 Jkt 059200 PO 00000 Frm 00009 Fmt 6652 Sfmt 6301 E:\BILLS\S233.IS S233
259	259	ssavage on LAPJG3WLY3PROD with BILLS